The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anti-Infective Drugs-Global Market Insights and Sales Trends 2025
Synopsis
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The global Anti-Infective Drugs market size is expected to reach US$ 272130 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Infective Drugs in various end use industries. The expanding demands from the Hospital, Drugs Store and Other, are propelling Anti-Infective Drugs market. OTC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rx Drugs segment is estimated at % CAGR for the next seven-year period.
The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Infective Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Infective Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Infective Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Infective Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Infective Drugs covered in this report include GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Sanofi-Aventis, Bristol-Myers Squibb and Johnson, etc.
The global Anti-Infective Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
Global Anti-Infective Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Infective Drugs market, Segment by Type:
OTC
Rx Drugs
Global Anti-Infective Drugs market, by Application
Hospital
Drugs Store
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anti-Infective Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The global Anti-Infective Drugs market size is expected to reach US$ 272130 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anti-Infective Drugs in various end use industries. The expanding demands from the Hospital, Drugs Store and Other, are propelling Anti-Infective Drugs market. OTC, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rx Drugs segment is estimated at % CAGR for the next seven-year period.
The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-Infective Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-Infective Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-Infective Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-Infective Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-Infective Drugs covered in this report include GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Sanofi-Aventis, Bristol-Myers Squibb and Johnson, etc.
The global Anti-Infective Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
Global Anti-Infective Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-Infective Drugs market, Segment by Type:
OTC
Rx Drugs
Global Anti-Infective Drugs market, by Application
Hospital
Drugs Store
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anti-Infective Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Anti-Infective Drugs
1.1 Anti-Infective Drugs Market Overview
1.1.1 Anti-Infective Drugs Product Scope
1.1.2 Anti-Infective Drugs Market Status and Outlook
1.2 Global Anti-Infective Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anti-Infective Drugs Market Size by Region (2018-2029)
1.4 Global Anti-Infective Drugs Historic Market Size by Region (2018-2023)
1.5 Global Anti-Infective Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anti-Infective Drugs Market Size (2018-2029)
1.6.1 North America Anti-Infective Drugs Market Size (2018-2029)
1.6.2 Europe Anti-Infective Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Anti-Infective Drugs Market Size (2018-2029)
1.6.4 Latin America Anti-Infective Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Anti-Infective Drugs Market Size (2018-2029)
2 Anti-Infective Drugs Market by Type
2.1 Introduction
2.1.1 OTC
2.1.2 Rx Drugs
2.2 Global Anti-Infective Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anti-Infective Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Anti-Infective Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anti-Infective Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anti-Infective Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anti-Infective Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anti-Infective Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anti-Infective Drugs Revenue Breakdown by Type (2018-2029)
3 Anti-Infective Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Drugs Store
3.1.3 Other
3.2 Global Anti-Infective Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anti-Infective Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Anti-Infective Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anti-Infective Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anti-Infective Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anti-Infective Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anti-Infective Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anti-Infective Drugs Revenue Breakdown by Application (2018-2029)
4 Anti-Infective Drugs Competition Analysis by Players
4.1 Global Anti-Infective Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Drugs as of 2022)
4.3 Date of Key Players Enter into Anti-Infective Drugs Market
4.4 Global Top Players Anti-Infective Drugs Headquarters and Area Served
4.5 Key Players Anti-Infective Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Anti-Infective Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GlaxoSmithKline
5.1.1 GlaxoSmithKline Profile
5.1.2 GlaxoSmithKline Main Business
5.1.3 GlaxoSmithKline Anti-Infective Drugs Products, Services and Solutions
5.1.4 GlaxoSmithKline Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 GlaxoSmithKline Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Anti-Infective Drugs Products, Services and Solutions
5.2.4 Merck Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Anti-Infective Drugs Products, Services and Solutions
5.3.4 Pfizer Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis AG Recent Developments
5.4 Novartis AG
5.4.1 Novartis AG Profile
5.4.2 Novartis AG Main Business
5.4.3 Novartis AG Anti-Infective Drugs Products, Services and Solutions
5.4.4 Novartis AG Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis AG Recent Developments
5.5 Gilead Sciences
5.5.1 Gilead Sciences Profile
5.5.2 Gilead Sciences Main Business
5.5.3 Gilead Sciences Anti-Infective Drugs Products, Services and Solutions
5.5.4 Gilead Sciences Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Gilead Sciences Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Anti-Infective Drugs Products, Services and Solutions
5.6.4 Abbott Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 Sanofi-Aventis
5.7.1 Sanofi-Aventis Profile
5.7.2 Sanofi-Aventis Main Business
5.7.3 Sanofi-Aventis Anti-Infective Drugs Products, Services and Solutions
5.7.4 Sanofi-Aventis Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi-Aventis Recent Developments
5.8 Bristol-Myers Squibb
5.8.1 Bristol-Myers Squibb Profile
5.8.2 Bristol-Myers Squibb Main Business
5.8.3 Bristol-Myers Squibb Anti-Infective Drugs Products, Services and Solutions
5.8.4 Bristol-Myers Squibb Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Bristol-Myers Squibb Recent Developments
5.9 Johnson
5.9.1 Johnson Profile
5.9.2 Johnson Main Business
5.9.3 Johnson Anti-Infective Drugs Products, Services and Solutions
5.9.4 Johnson Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Johnson Recent Developments
5.10 Roche Pharma AG
5.10.1 Roche Pharma AG Profile
5.10.2 Roche Pharma AG Main Business
5.10.3 Roche Pharma AG Anti-Infective Drugs Products, Services and Solutions
5.10.4 Roche Pharma AG Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Roche Pharma AG Recent Developments
5.11 Nanosphere
5.11.1 Nanosphere Profile
5.11.2 Nanosphere Main Business
5.11.3 Nanosphere Anti-Infective Drugs Products, Services and Solutions
5.11.4 Nanosphere Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Nanosphere Recent Developments
5.12 NanoViricides
5.12.1 NanoViricides Profile
5.12.2 NanoViricides Main Business
5.12.3 NanoViricides Anti-Infective Drugs Products, Services and Solutions
5.12.4 NanoViricides Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 NanoViricides Recent Developments
5.13 Novabay Pharmaceuticals
5.13.1 Novabay Pharmaceuticals Profile
5.13.2 Novabay Pharmaceuticals Main Business
5.13.3 Novabay Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions
5.13.4 Novabay Pharmaceuticals Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.13.5 Novabay Pharmaceuticals Recent Developments
5.14 Obetech
5.14.1 Obetech Profile
5.14.2 Obetech Main Business
5.14.3 Obetech Anti-Infective Drugs Products, Services and Solutions
5.14.4 Obetech Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.14.5 Obetech Recent Developments
5.15 Optimer Pharmaceuticals
5.15.1 Optimer Pharmaceuticals Profile
5.15.2 Optimer Pharmaceuticals Main Business
5.15.3 Optimer Pharmaceuticals Anti-Infective Drugs Products, Services and Solutions
5.15.4 Optimer Pharmaceuticals Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.15.5 Optimer Pharmaceuticals Recent Developments
5.16 Basilea Pharmaceutica AG
5.16.1 Basilea Pharmaceutica AG Profile
5.16.2 Basilea Pharmaceutica AG Main Business
5.16.3 Basilea Pharmaceutica AG Anti-Infective Drugs Products, Services and Solutions
5.16.4 Basilea Pharmaceutica AG Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.16.5 Basilea Pharmaceutica AG Recent Developments
5.17 Daiichi Sankyo
5.17.1 Daiichi Sankyo Profile
5.17.2 Daiichi Sankyo Main Business
5.17.3 Daiichi Sankyo Anti-Infective Drugs Products, Services and Solutions
5.17.4 Daiichi Sankyo Anti-Infective Drugs Revenue (US$ Million) & (2018-2023)
5.17.5 Daiichi Sankyo Recent Developments
6 North America
6.1 North America Anti-Infective Drugs Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Anti-Infective Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anti-Infective Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anti-Infective Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anti-Infective Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anti-Infective Drugs Market Dynamics
11.1 Anti-Infective Drugs Industry Trends
11.2 Anti-Infective Drugs Market Drivers
11.3 Anti-Infective Drugs Market Challenges
11.4 Anti-Infective Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
